CHEK1 and neoplasm: It has been shown that inhibition of Chk1 signaling using small molecule inhibitors, dominant negative constructs, interference RNA (RNAi), or ribozymes leads to abrogation the G2/M checkpoint, impaired DNA repair, sensitization of p53-deficient cells to apoptosis, and an increase in tumor cell death [13-15].